发现了新型胺衍生物作为读透诱导药物
Shota Kawai1, Shunsuke Takashima1, Masafumi Ando1
1Drug Discovery Research Department, Kyoto Pharmaceutical Industries, Ltd.
Chemical & pharmaceutical bulletin
|December 3, 2023
概括
新的chromenopyridine衍生物显示出对赫勒综合征治疗的希望. 这些化合物可以恢复α-L-iduronidase (IDUA) 蛋白质的产生,通过使过早停止密码子的读取,为这种遗传性疾病提供治疗潜力.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 赫勒综合征是一种I型的粘多糖,源于缺少的α-L-氨基酶 (IDUA) 活性.
- 这种缺陷导致有毒的糖氨基 (GAG) 积累,导致多器官功能障碍.
- 无意义的突变通常会阻止IDUA蛋白质的产生,从而成为阅读疗法的目标.
研究的目的:
- 为了合成和评估新型chromenopyridine衍生物作为读透诱导化合物.
- 为了确定能够恢复IDUA蛋白表达在赫勒综合征患者细胞中的化合物.
- 在临床前模型中评估有前途的候选者的治疗潜力.
主要方法:
- 合成多种不同的chromenopyridine衍生物.
- 在赫勒综合征患者衍生细胞中测定细胞IDUA活性.
- 在经过处理的细胞中测量GAG度.
- 在小鼠模型中评估酶活性.
主要成果:
- 几种chromenopyridine衍生物显示出显著的读透诱导活性.
- 最优的化合物具有特定的替代物:二二基,环基和基本侧链或化环.
- 值得注意的一种衍生品KY-640在0.3μM时增强了细胞IDUA活性3.2倍,并降低了GAG水平.
- 在小鼠模型中,KY-640还改善了酶活性.
结论:
- 克罗米诺皮里丁衍生物是Hurler综合征的有效读透诱导剂.
- KY-640对赫勒综合征具有显著的治疗潜力.
- 进一步开发KY-640可能会导致这种遗传性疾病的新疗法.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
576
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
576
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.0K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
994
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
994
CNS Stimulants: Psychedelic Agents
156
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
156


